Neurology · PANCE / PANRE

Ménière Disease

Inner-ear disorder of recurrent vertigo episodes, fluctuating low-frequency sensorineural hearing loss, tinnitus, and aural fullness.

Also known as: Meniere disease, endolymphatic hydrops, Ménière's disease

Overview

An idiopathic inner-ear disorder characterized by recurrent spontaneous episodes of vertigo lasting 20 minutes to 12 hours, accompanied by fluctuating low- to mid-frequency sensorineural hearing loss, tinnitus, and aural fullness in the affected ear (per Bárány Society / AAO-HNS criteria).

Epidemiology

Prevalence ~200 per 100,000. Onset typically between ages 40 and 60. Female predominance ~1.3:1. Bilateral involvement develops in 25-50% over years. Genetic predisposition (HLA associations, familial clusters).

Try two board-style Ménière Disease questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1NeurologyMedium
A 49-year-old woman has episodic vertigo lasting hours, fluctuating hearing loss, tinnitus, and aural fullness. Which of the following best explains this disorder?
  • AExcess endolymphatic fluid pressure
  • BOtoliths displaced into the posterior canal
  • CVestibular schwannoma compressing CN VIII
  • DCerebellar infarction from an embolus
  • EReactivation of vestibular nerve herpesvirus
Reveal answer & full explanation
Correct answer: A — Excess endolymphatic fluid pressure
  • AExcess endolymphatic fluid pressure✓
  • BOtoliths displaced into the posterior canal
  • CVestibular schwannoma compressing CN VIII
  • DCerebellar infarction from an embolus
  • EReactivation of vestibular nerve herpesvirus

Why Excess endolymphatic fluid pressure is correct

  • Ménière disease reflects endolymphatic hydrops, an overaccumulation of endolymph that distends the membranous labyrinth.
  • This produces the classic tetrad of episodic vertigo lasting 20 minutes to hours, fluctuating sensorineural hearing loss, tinnitus, and aural fullness.
  • The cochlear plus vestibular involvement together distinguish it from purely positional or purely vestibular causes.

Why the others are wrong

  • Otoliths displaced into the posterior canal — Canalithiasis causes BPPV, which is brief seconds-long positional vertigo WITHOUT hearing loss or tinnitus (vertigo-subtype trap).
  • Reactivation of vestibular nerve herpesvirus — Vestibular neuritis causes a single days-long vertiginous spell after a viral illness and spares hearing, unlike this fluctuating cochlear picture (right-organ-wrong-pattern).
  • Cerebellar infarction from an embolus — A cerebellar stroke gives continuous vertigo with ataxia and other neurologic deficits, not recurrent attacks with aural fullness (dangerous-mimic trap).
  • Vestibular schwannoma compressing CN VIII — An acoustic neuroma also causes sensorineural hearing loss and tinnitus, but the hearing loss is typically slowly progressive rather than fluctuating, and the slow growth allows central compensation, so patients usually have mild chronic imbalance rather than discrete hours-long vertigo attacks (hearing-loss-overlap trap).
Question 2NeurologyMedium
A 48-year-old woman presents with a 6-month history of recurrent spontaneous episodes of spinning vertigo, each lasting 2 to 3 hours and accompanied by nausea and vomiting. During the episodes she notices a roaring, low-pitched ringing and a sense of pressure in her right ear, along with muffled hearing on that side that improves between attacks. She denies positional triggers. An audiogram performed after a recent attack shows fluctuating low-frequency sensorineural hearing loss in the right ear, and MRI of the internal auditory canals is normal. Which of the following is the most likely diagnosis?
  • AMénière disease
  • BVestibular migraine
  • CVestibular neuritis
  • DViral labyrinthitis
  • EVertebrobasilar insufficiency
Reveal answer & full explanation
Correct answer: A — Ménière disease
  • AMénière disease✓
  • BVestibular migraine
  • CVestibular neuritis
  • DViral labyrinthitis
  • EVertebrobasilar insufficiency

Why Ménière disease is correct

  • The Bárány Society / AAO-HNS 2015 criteria define definite Ménière disease as ≥2 episodes of spontaneous vertigo lasting 20 minutes to 12 hours, plus audiometrically documented low- to mid-frequency sensorineural hearing loss in the affected ear, plus fluctuating aural symptoms (hearing loss, tinnitus, fullness) in that ear, with no better explanation.
  • This patient hits every element: recurrent 2-3 hour spontaneous vertigo, unilateral fluctuating low-frequency SNHL on audiogram, roaring low-pitched tinnitus, and aural fullness on the right.
  • A normal MRI of the internal auditory canals appropriately excludes vestibular schwannoma, supporting the clinical diagnosis.

Why the others are wrong

  • Vertebrobasilar insufficiency — posterior circulation ischemia produces vertigo accompanied by brainstem or cerebellar signs such as diplopia, dysarthria, ataxia, or visual field loss, and spells usually last minutes; it does not cause 6 months of recurrent attacks with fluctuating low-frequency sensorineural hearing loss, roaring tinnitus, and aural fullness confined to one ear.
  • Vestibular migraine — the most common Ménière mimic, and it can produce recurrent spontaneous vertigo of similar duration, but hearing is characteristically preserved; audiometrically documented fluctuating low-frequency sensorineural hearing loss with aural fullness in one ear points to endolymphatic hydrops instead.
  • Vestibular neuritis — a single prolonged attack of vertigo lasting days after a viral illness, without hearing loss; it does not recur episodically and spares cochlear function.
  • Viral labyrinthitis — vertigo accompanied by unilateral hearing loss and tinnitus is tempting, but labyrinthitis is a single acute attack of continuous vertigo lasting days, often after a viral illness, with hearing loss that does not fluctuate with recurrent attacks; 6 months of recurrent 2-3 hour spells with fluctuating low-frequency loss points to endolymphatic hydrops.

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Ménière Disease outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Family history of Ménière disease
  • Autoimmune inner ear disease
  • Migraine (overlap with vestibular migraine)
  • Allergic disorders
  • Possible viral or immune triggers

Pathophysiology

Endolymphatic hydrops — overaccumulation of endolymph distends the scala media and may rupture Reissner's membrane, producing acute potassium-induced injury to vestibular and cochlear hair cells. Etiology of hydrops is multifactorial: impaired endolymph absorption at the endolymphatic sac, autoimmune injury, ionic dysregulation, viral.

Clinical presentation

Symptoms

  • Episodic spontaneous vertigo lasting 20 min to 12 h (rarely up to 24 h)
  • Fluctuating low- to mid-frequency sensorineural hearing loss, typically unilateral
  • Roaring or low-pitched tinnitus that may worsen during episodes
  • Aural fullness or pressure in the affected ear
  • Nausea, vomiting, diaphoresis during episodes
  • Tumarkin 'otolithic crisis' drop attacks (sudden falls without warning, no LOC) in advanced disease

Signs / physical exam

  • Between attacks: exam often normal; later, persistent unilateral sensorineural hearing loss on audiogram
  • Spontaneous horizontal-torsional nystagmus during attacks (initially toward the affected ear in irritative phase, then away as the labyrinth fatigues)
  • Positive head-impulse test toward the affected side once vestibular function is reduced
  • Tuning fork tests (Weber, Rinne) consistent with unilateral SNHL

Classic findings

Recurrent spontaneous vertigo + unilateral low-frequency hearing loss + tinnitus + aural fullness.

Differential diagnosis

  • Vestibular migraine — Recurrent vertigo + migraine features (headache, photophobia, phonophobia, aura); hearing usually normal; responds to migraine prophylaxis
  • BPPV — Brief (seconds), positional vertigo with Dix-Hallpike; no hearing loss; treated with Epley maneuver
  • Vestibular neuritis — Single prolonged episode (days), no hearing loss, follows viral illness; unilateral caloric weakness
  • Labyrinthitis — Single episode with hearing loss; viral or bacterial; does not recur in classic form
  • Acoustic neuroma (vestibular schwannoma) — Progressive unilateral hearing loss + tinnitus; vertigo less prominent; MRI internal auditory canal diagnostic
  • Autoimmune inner ear disease — Bilateral, rapidly progressive sensorineural hearing loss; steroid-responsive
  • Perilymph fistula — Vertigo triggered by Valsalva, sneezing, or pressure changes; recent barotrauma or head injury
  • Posterior circulation TIA/stroke (vertebrobasilar ischemia, cerebellar infarct) — Vertigo with brainstem/cerebellar signs (diplopia, dysarthria, ataxia, visual field loss); spells last minutes or the deficit persists; vascular risk factors; no fluctuating low-frequency SNHL or aural fullness

Diagnostic workup

Diagnostic criteria

Definite Ménière (Bárány/AAO-HNS 2015): ≥2 episodes of spontaneous vertigo lasting 20 min to 12 h + audiometrically documented low- to mid-frequency SNHL in the affected ear before, during, or after an episode + fluctuating aural symptoms (hearing loss, tinnitus, fullness) in the affected ear + no better explanation.

Labs

  • TSH, CBC, comprehensive metabolic panel, ANA, RPR, B12 (exclude metabolic/autoimmune mimics)
  • Lyme serology in endemic areas

Imaging

  • Pure-tone and speech audiometry — low/mid-frequency SNHL, often fluctuating; word recognition typically preserved early
  • MRI with gadolinium of internal auditory canals — exclude vestibular schwannoma and central pathology
  • Vestibular testing (videonystagmography, caloric, VEMPs) — not needed to establish the diagnosis (AAO-HNS 2020 recommends against ordering it for that purpose); reserved for unclear cases or before ablative therapy
  • Electrocochleography — elevated SP/AP ratio supports hydrops, but it is not recommended to establish the diagnosis (AAO-HNS 2020)
  • Delayed gadolinium-enhanced MRI inner ear (specialized centers) can visualize hydrops

Treatment

First-line

  • Low-sodium diet (<2 g/day), caffeine and alcohol reduction, smoking cessation
  • Thiazide diuretic (hydrochlorothiazide, often combined with triamterene) or acetazolamide — to reduce endolymph volume
  • Vestibular suppressants for acute attacks: meclizine, dimenhydrinate, promethazine, lorazepam, prochlorperazine — limit to acute use; chronic use impairs vestibular compensation
  • Antiemetics (ondansetron, prochlorperazine) for nausea
  • Patient education and reassurance about benign nature of attacks
  • Vestibular rehabilitation for interictal imbalance

Persistent or refractory disease

  • Intratympanic corticosteroid (dexamethasone) injections — vestibular-sparing, may help hearing and vertigo
  • Intratympanic gentamicin — selectively ablates vestibular hair cells; controls vertigo at the cost of vestibular function (and some hearing risk)
  • Endolymphatic sac decompression — controversial benefit
  • Selective vestibular nerve section — preserves hearing; effective for vertigo control in serviceable-hearing patients
  • Labyrinthectomy — definitive vertigo control but destroys hearing; reserved for non-serviceable hearing

Migraine overlap

  • Trial migraine prophylaxis (propranolol, topiramate, amitriptyline, venlafaxine, magnesium) if vestibular migraine features present
  • Lifestyle measures: sleep, hydration, trigger avoidance

Second-line / adjunct

  • Betahistine — used widely outside the US; evidence mixed; not FDA-approved
  • Hearing aids for permanent SNHL; cochlear implant for severe bilateral hearing loss
  • Counseling and support groups for chronic disease impact

Complications

  • Progressive permanent sensorineural hearing loss
  • Bilateral involvement with cumulative hearing and balance disability
  • Drop attacks (Tumarkin crises) with fall-related injury
  • Chronic anxiety and depression
  • Loss of driving privileges and employment impact
  • Persistent disequilibrium between episodes

PANCE pearls

  • The combination of low-frequency SNHL with fluctuation is highly specific for Ménière — pure high-frequency loss argues for presbycusis or noise exposure.
  • Always image with MRI to exclude vestibular schwannoma before settling on Ménière, especially with unilateral hearing loss.
  • Vestibular migraine is the most common Ménière mimic — overlapping features include episodic vertigo, photophobia, and family history of migraine.
  • Intratympanic gentamicin trades vestibular function for vertigo control; counsel about persistent imbalance.
  • Avoid chronic vestibular suppressants — they prevent central compensation.

References

  • Bárány Society 2015 — Lopez-Escamez JA et al. Diagnostic criteria for Ménière's disease. J Vestib Res 2015;25:1-7.
  • AAO-HNS 2020 — Basura GJ et al. Clinical practice guideline: Ménière's disease. Otolaryngol Head Neck Surg 2020;162(2_suppl):S1-S55.

Practice Neurology questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.